Paraneoplastic Syndromes - 51 Studies Found
Completed |
: Immunotherapy of the Paraneoplastic Syndromes : Paraneoplastic Syndromes : 2006-09-18 : Drug: Tacrolimus Tacrolimus at doses of 0.15- 0.3mg/kg/day in two divided oral doses, in conjunction wit |
Completed |
: Studies of Neurological Paraneoplastic Syndromes : Paraneoplastic Neurologic Degenerations (PNDs) : 2007-12-21 |
Recruiting |
: The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes : Paraneoplastic Syndromes : 2006-05-17 |
Completed |
: One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study :
|
Completed |
: Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone :
|
Completed |
: Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer :
|
Withdrawn |
: S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone :
|
Completed |
: Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases :
|
Completed |
: Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone :
|
Active, not recruiting |
: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China : Anti-NMDA Receptor Enphalitis : 2015-09-23 |